Related Experiment Video
Updated: Dec 23, 2025

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
Multi-parameter flow cytometry immunophenotyping distinguishes different stages of tuberculosis infection
Olivia Estévez1, Luis Anibarro2, Elina Garet1
1CINBIO, Universidade de Vigo, Immunology Group, Campus universitario Lagoas, Marcosende, 36310 Vigo, Spain; Instituto de Investigación Sanitaria Galicia Sur (IIS-GS), Spain.
Insights
New blood biomarkers can help diagnose active tuberculosis (TB). Researchers found specific T-cell subsets and ratios in leukocytes differentiate active TB from latent infection or no TB exposure.
Area of Science:
- Immunology
- Infectious Diseases
- Biomarker Discovery
Background:
- Accurate diagnosis of active tuberculosis (TB) is crucial for effective treatment and control.
- Current diagnostic methods have limitations, necessitating the search for novel host biomarkers.
- Distinguishing active TB from latent TB infection (LTBI) and uninfected individuals is a diagnostic challenge.
Purpose of the Study:
- To identify novel host biomarkers in blood for differentiating active TB patients from uninfected (NoTBI) and latently infected contacts (LTBI).
- To evaluate the diagnostic accuracy of identified biomarkers using multi-parameter flow cytometry.
Main Methods:
- Blood cell counts were performed to analyze leukocyte populations.
- Peripheral blood mononuclear cells (PBMCs) were isolated for multi-parameter flow cytometry.
- Basal and Mycobacterium tuberculosis (Mtb)-stimulated lymphocyte distribution and expression were analyzed, with diagnostic accuracy assessed by Area Under the ROC Curve (AUC).
Main Results:
- Active TB patients showed significantly higher Monocyte-to-lymphocyte and Neutrophil-to-lymphocyte ratios (AUC >0.8).
- Differences in basal Th1/Th2 ratio, Th1-Th17, CD4+ Central Memory (TCM), and MAIT cells distinguished active TB from contact groups (AUC >0.7).
- Mtb-stimulated CD4+ TCM cells expressing CD154 demonstrated higher accuracy than IFNγ in discriminating Mtb-specific activation.
Conclusions:
- Specific leukocyte ratios and lymphocyte subsets serve as potential diagnostic biomarkers for tuberculosis.
- The distribution of CD4+ TCM cells and their CD154 expression post-Mtb activation are highly promising for TB diagnosis.
Objectives:
To identify new potential host biomarkers in blood to discriminate between active TB patients, uninfected (NoTBI) and latently infected contacts (LTBI).
Methods:
A blood cell count was performed to study parent leukocyte populations. Peripheral blood mononuclear cells (PBMCs) were isolated and a multi-parameter flow cytometry assay was conducted to study the distribution of basal and Mycobacterium tuberculosis (Mtb)-stimulated lymphocytes. Differences between groups and the area under the ROC curve (AUC) were investigated to assess the diagnostic accuracy.
Results:
Active TB patients presented higher Monocyte-to-lymphocyte and Neutrophil-to-lymphocyte ratios than LTBI and NoTBI contacts (p<0.0001; AUC>0.8). Lymphocyte subsets with differences (p >0.05; AUC >0.7) between active TB and both contact groups include the basal distribution of Th1/Th2 ratio, Th1-Th17, CD4+ Central Memory (TCM) or MAIT cells. Expression of CD154 is increased in Mtb-activated CD4+ TCM and Effector Memory T cells in active TB and LTBI compared to NoTBI. In CD4+T cells, expression of CD154 showed a higher accuracy than IFNγ to discriminate Mtb-specific activation.
Conclusions:
We identified different cell subsets with potential use in tuberculosis diagnosis. Among them, distribution of CD4 TCM cells and their expression of CD154 after Mtb-activation are the most promising candidates.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Flow Cytometry
In...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

